Parkwood LLC Ascendis Pharma A/S Transaction History

Parkwood LLC

$1.42 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$121.07 - $153.67 $175,430 - $222,667	1,449 Added 11.83%	13,696 $1.87 Million
Q1 2024 May 15, 2024	SELL	$123.45 - $159.4 $475,159 - $613,530	-3,849 Reduced 23.91%	12,247 $1.85 Million
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $172,286 - $254,847	-2,001 Reduced 11.06%	16,096 $2.03 Million
Q3 2023 Nov 14, 2023	SELL	$86.5 - $103.97 $44,547 - $53,544	-515 Reduced 2.77%	18,097 $1.7 Million
Q2 2023 Aug 14, 2023	SELL	$69.96 - $97.84 $4,617 - $6,457	-66 Reduced 0.35%	18,612 $1.66 Million
Q1 2023 May 15, 2023	BUY	$104.9 - $126.78 $118,012 - $142,627	1,125 Added 6.41%	18,678 $2 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $285,931 - $379,545	-2,876 Reduced 14.08%	17,553 $2.14 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $237,300 - $311,289	2,824 Added 16.04%	20,429 $2.11 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $94,867 - $142,896	-1,215 Reduced 6.46%	17,605 $18,000
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $201,498 - $267,699	-1,972 Reduced 9.48%	18,820 $2.21 Million
Q4 2021 Feb 11, 2022	SELL	$127.1 - $169.66 $429,598 - $573,450	-3,380 Reduced 13.98%	20,792 $2.8 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $675,118 - $1.06 Million	5,992 Added 32.96%	24,172 $3.85 Million
Q2 2021 Aug 13, 2021	SELL	$121.62 - $145.29 $368,508 - $440,228	-3,030 Reduced 14.29%	18,180 $2.39 Million
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $512,671 - $711,346	-4,104 Reduced 16.21%	21,210 $2.73 Million
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $4.98 Million - $6.02 Million	-32,928 Reduced 56.54%	25,314 $4.22 Million
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $3.37 Million - $3.87 Million	25,081 Added 75.63%	58,242 $5.84 Million
Q2 2020 Aug 11, 2020	BUY	$110.87 - $156.01 $3.68 Million - $5.17 Million	33,161 New	33,161 $4.91 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.

Account